Euro Medicines Agency Updates List of Tenders
On March 13, the European Medicines Agency published updated information about current tenders...
On March 13, the European Medicines Agency (EMA) published updated information about current tenders—documents that explain a project and its requirements to intending bidders—worth more than £60,000 ($99,700).
The newest tender to be unveiled consists of a contract worth 1.2 million euros for the provision of information resources at the Agency itself. The closing date is June 4, 2014.
Further details about the latest tenders—which typically contain a notice inviting tenders, instructions to bidders, the conditions, form of submission, and bill of quantities—are available via this link:
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
